In addition, for cases of overlap between FD and proton pump inhibitor (PPI)-resistant gastroesophageal reflux disease(GERD), it was also reported that there was no statistically significant difference between the high-dose PPI and supplementary acotiamide groups. Prokinetics is expected to be ...
Prokinetic agents have been widely employed in pediatric patients in order to reduce the symptoms of GERD. These drugs seem to enhance lower esophageal sphincter (LES) tone, to improve esophageal clearance, and to increase gastric motility thus increasing emptying of gastric contents. Cisapride was ...
Lifestyle management GERD lifestyle changes 最好的學習方式。免費註冊。 註冊代表你接受Quizlet的服務條款和隱私政策 以Google帳戶繼續 關於我們 關於Quizlet 職涯 廣告合作 身為學生的你 單詞卡 測試 學習 解答 Modern Learning Lab Quizlet Plus 學習指南 番茄工作法計時器 教師專區 Live 檢查小站 部落格 Quizlet...
Gastroesophageal reflux disease (GERD) is often confused with functional dyspepsia as dyspepsia symptom commonly coexist with heartburn and some patients with functional dyspepsia respond to proton pump inhibitor (PPI) therapy. Up to 25鈥 50% of patients with functional dyspepsia defined according to ...
In addition, for cases of overlap between FD and proton pump inhibitor (PPI)-resistant gastroesophageal reflux disease(GERD), it was also reported that there was no statistically significant difference between the high-dose PPI and supplementary acotiamide groups. Prokinetics is expected to be ...
(combined therapy)for GERD.The primary outcome of those selected trials was complete or partial relief of non-erosive reflux disease symptoms or mucosal healing in erosive reflux esophagitis.Using the test of heterogeneity,we established a fixed or random effects model where the risk ratio was the...
investigated whether pretreatment scores for the Frequency Scale for the Symptoms of GERD (FSSG, a GERD-specific questionnaire) could be used to predict the need for prokinetics.doi:10.1038/ncpgasthep1171NoneNature Clinical Practice Gastroenterology & 38 Hepatology...
Frequency scale for the symptoms of GERD (FSSG) questionnairegastroesophageal reflux diseaseproton pump inhibitor therapyprokineticsBackground and Aim: Proton pump inhibitor (PPI) monotherapy cannot cure all cases of gastroesophageal reflux disease (GERD), and combination therapy with prokinetics and PPI ...
Meta-analysisAIM: To investigate the efficacy of adding prokinetics to proton pump inhibitors (PPIs) for the treatment of gastroesophageal reflux disease (GERD).Ren, Li-HuaChen, Wei-XuQian, Li-JuanLi, ShuoGu, MinShi, Rui-HuaWorld Journal of Gastroenterology...
Cisapride has been used as a prokinetic agent since 1991 and has successfully been applied both in humans and animals as a medication for many different illnesses, among others, gastro-esophageal relax disease (GERD) and gastroparesis. However, Cisapride is still a controversial drug and, despite...